{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:55:39Z","timestamp":1781643339091,"version":"3.54.5"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T00:00:00Z","timestamp":1773705600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2023MH341"],"award-info":[{"award-number":["ZR2023MH341"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"name":"SDU-KI Collaborative Research Project of Qilu Medical College, Shandong University","award":["No. SDU-KI-2019-15"],"award-info":[{"award-number":["No. SDU-KI-2019-15"]}]},{"DOI":"10.13039\/100014103","name":"Key Research and Development Program of Shandong Province","doi-asserted-by":"crossref","award":["2021CXGC011101"],"award-info":[{"award-number":["2021CXGC011101"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The rapid emergence of multidrug-resistant (MDR) bacteria poses a critical challenge in hospital-acquired infections, particularly methicillin-resistant\n                    <jats:italic>Staphylococcus aureus<\/jats:italic>\n                    (MRSA) pneumonia. Antimicrobial peptides (AMPs) are promising therapeutic candidates due to their broad-spectrum antibacterial activity. Here, we report AMP-36, a 36-amino acid antimicrobial peptide rationally designed and synthesized from SAAP-148, exhibits potent antibacterial activity. AMP-36 displayed low micromolar minimum inhibitory concentrations and rapid bactericidal activity in vitro, achieving near-complete bacterial killing within 8\u00a0h. In the murine pneumonia model, AMP-36 significantly reduced bacterial burden in bronchoalveolar lavage fluid (BALF) and markedly alleviated lung inflammation. Scanning electron microscopy (SEM) revealed pronounced disruption of MRSA cell membranes following AMP-36 treatment, indicating membrane damage as the primary antibacterial mechanism. Transcriptomic analysis further demonstrated its broad transcriptional alterations. Collectively, these findings highlight AMP-36 as a promising therapeutic candidate for MRSA pneumonia and provide mechanistic insights into its antimicrobial action.\n                  <\/jats:p>","DOI":"10.1038\/s41598-026-44156-6","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T17:14:23Z","timestamp":1773767663000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["AMP-36 exhibits potent therapeutic efficacy against MRSA pneumonia through membrane-target mechanism"],"prefix":"10.1038","volume":"16","author":[{"given":"Yanxiao","family":"Han","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenxi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jialin","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuhua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexiao","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengyun","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,17]]},"reference":[{"key":"44156_CR1","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1164\/ajrccm.165.7.2105078","volume":"165","author":"J Chastre","year":"2002","unstructured":"Chastre, J. & Fagon, J. Y. Ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 165, 867\u2013903. https:\/\/doi.org\/10.1164\/ajrccm.165.7.2105078 (2002).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"44156_CR2","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1378\/chest.127.1.213","volume":"127","author":"N Sopena","year":"2005","unstructured":"Sopena, N. & Sabri\u00e0, M. Multicenter study of hospital-acquired pneumonia in non-ICU patients. Chest 127, 213\u2013219. https:\/\/doi.org\/10.1378\/chest.127.1.213 (2005).","journal-title":"Chest"},{"key":"44156_CR3","doi-asserted-by":"publisher","DOI":"10.2174\/1871526523666230725103902","volume":"24","author":"JA Alara","year":"2024","unstructured":"Alara, J. A. & Alara, O. R. An overview of the global alarming increase of multiple drug resistant: A major challenge in clinical diagnosis. Infect. Disord. Drug. Target. 24, e250723219043. https:\/\/doi.org\/10.2174\/1871526523666230725103902 (2024).","journal-title":"Infect. Disord. Drug. Target."},{"key":"44156_CR4","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrmicro2200","volume":"7","author":"HF Chambers","year":"2009","unstructured":"Chambers, H. F. & Deleo, F. R. Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7, 629\u2013641. https:\/\/doi.org\/10.1038\/nrmicro2200 (2009).","journal-title":"Nat. Rev. Microbiol."},{"key":"44156_CR5","doi-asserted-by":"publisher","DOI":"10.1128\/cmr.00107-18","author":"JA Grousd","year":"2019","unstructured":"Grousd, J. A., Rich, H. E. & Alcorn, J. F. Host-pathogen interactions in Gram-positive bacterial pneumonia. Clin. Microbiol. Rev. https:\/\/doi.org\/10.1128\/cmr.00107-18 (2019).","journal-title":"Clin. Microbiol. Rev."},{"key":"44156_CR6","doi-asserted-by":"publisher","first-page":"2836","DOI":"10.1172\/jci68834","volume":"124","author":"S Gardete","year":"2014","unstructured":"Gardete, S. & Tomasz, A. Mechanisms of vancomycin resistance in Staphylococcus aureus. J. Clin. Invest. 124, 2836\u20132840. https:\/\/doi.org\/10.1172\/jci68834 (2014).","journal-title":"J. Clin. Invest."},{"key":"44156_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00194","volume":"6","author":"M Mahlapuu","year":"2016","unstructured":"Mahlapuu, M., H\u00e5kansson, J., Ringstad, L. & Bj\u00f6rn, C. Antimicrobial peptides: An emerging category of therapeutic agents. Front. Cell. Infect. Microbiol. 6, 194. https:\/\/doi.org\/10.3389\/fcimb.2016.00194 (2016).","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"3","key":"44156_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.jaad.2004.08.026","volume":"52","author":"A Izadpanah","year":"2005","unstructured":"Izadpanah, A. & Gallo, R. L. Antimicrobial peptides. J. Am. Acad. Dermatol. 52(3), 381\u2013390. https:\/\/doi.org\/10.1016\/j.jaad.2004.08.026 (2005).","journal-title":"J. Am. Acad. Dermatol."},{"key":"44156_CR9","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.actbio.2024.12.002","volume":"192","author":"P Chen","year":"2025","unstructured":"Chen, P. et al. Aggregation-prone antimicrobial peptides target gram-negative bacterial nucleic acids and protein synthesis. Acta Biomater. 192, 446\u2013460. https:\/\/doi.org\/10.1016\/j.actbio.2024.12.002 (2025).","journal-title":"Acta Biomater."},{"key":"44156_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42374-4","volume":"14","author":"T Sneideris","year":"2023","unstructured":"Sneideris, T. et al. Targeting nucleic acid phase transitions as a mechanism of action for antimicrobial peptides. Nat. Commun. 14, 7170. https:\/\/doi.org\/10.1038\/s41467-023-42374-4 (2023).","journal-title":"Nat. Commun."},{"key":"44156_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-023-05254-7","volume":"6","author":"CN Pedron","year":"2023","unstructured":"Pedron, C. N. et al. Molecular hybridization strategy for tuning bioactive peptide function. Commun. Biol. 6, 1067. https:\/\/doi.org\/10.1038\/s42003-023-05254-7 (2023).","journal-title":"Commun. Biol."},{"key":"44156_CR12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.24272\/j.issn.2095-8137.2023.246","volume":"44","author":"J Mwangi","year":"2023","unstructured":"Mwangi, J., Kamau, P. M., Thuku, R. C. & Lai, R. Design methods for antimicrobial peptides with improved performance. Zool. Res. 44, 1095\u20131114. https:\/\/doi.org\/10.24272\/j.issn.2095-8137.2023.246 (2023).","journal-title":"Zool. Res."},{"key":"44156_CR13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/978-981-13-3588-4_12","volume":"1117","author":"G Wang","year":"2019","unstructured":"Wang, G. et al. Design of antimicrobial peptides: progress made with human cathelicidin LL-37. Adv. Exp. Med. Biol. 1117, 215\u2013240. https:\/\/doi.org\/10.1007\/978-981-13-3588-4_12 (2019).","journal-title":"Adv. Exp. Med. Biol."},{"key":"44156_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2025.107624","volume":"204","author":"S Moulick","year":"2025","unstructured":"Moulick, S., Bera, R. & Roy, D. N. Bactericidal action of ginger (Zingiber officinale Roscoe) extract against Escherichia coli through synergistic modulation of the AcrAB-TolC efflux pump and inhibition of peptidoglycan synthesis: In vitro and in silico approaches. Microb. Pathog. 204, 107624. https:\/\/doi.org\/10.1016\/j.micpath.2025.107624 (2025).","journal-title":"Microb. Pathog."},{"key":"44156_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aan4044","author":"A de Breij","year":"2018","unstructured":"de Breij, A. et al. The antimicrobial peptide SAAP-148 combats drug-resistant bacteria and biofilms. Sci. Transl. Med. https:\/\/doi.org\/10.1126\/scitranslmed.aan4044 (2018).","journal-title":"Sci. Transl. Med."},{"key":"44156_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15020429","author":"ME van Gent","year":"2023","unstructured":"van Gent, M. E. et al. Encapsulation of SAAP-148 in octenyl succinic anhydride-modified hyaluronic acid nanogels for treatment of skin wound infections. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics15020429 (2023).","journal-title":"Pharmaceutics"},{"key":"44156_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/polym16060728","author":"AM Tolos Vasii","year":"2024","unstructured":"Tolos Vasii, A. M. et al. Anticancer potential of antimicrobial peptides: Focus on buforins. Polymers https:\/\/doi.org\/10.3390\/polym16060728 (2024).","journal-title":"Polymers"},{"key":"44156_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1006\/bbrc.1998.8159","volume":"244","author":"CB Park","year":"1998","unstructured":"Park, C. B., Kim, H. S. & Kim, S. C. Mechanism of action of the antimicrobial peptide buforin II: Buforin II kills microorganisms by penetrating the cell membrane and inhibiting cellular functions. Biochem. Biophys. Res. Commun. 244, 253\u2013257. https:\/\/doi.org\/10.1006\/bbrc.1998.8159 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"44156_CR19","doi-asserted-by":"publisher","DOI":"10.1042\/bsr20182455","author":"D Kong","year":"2019","unstructured":"Kong, D. et al. Mesenchymal stem cells significantly improved treatment effects of Linezolid on severe pneumonia in a rabbit model. Biosci. Rep. https:\/\/doi.org\/10.1042\/bsr20182455 (2019)."},{"key":"44156_CR20","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucl. Acid. Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucl. Acid. Res."},{"key":"44156_CR21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"44156_CR22","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Matsuura, Y. & Ishiguro-Watanabe, M. KEGG: Biological systems database as a model of the real world. Nucl. Acid. Res. 53, D672-d677. https:\/\/doi.org\/10.1093\/nar\/gkae909 (2025).","journal-title":"Nucl. Acid. Res."},{"key":"44156_CR23","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s00134-022-06968-8","volume":"49","author":"L Russell","year":"2023","unstructured":"Russell, L., P\u00e8ne, F. & Martin-Loeches, I. Multidrug-resistant bacteria in the grey shades of immunosuppression. Intensiv. Care Med. 49, 216\u2013218. https:\/\/doi.org\/10.1007\/s00134-022-06968-8 (2023).","journal-title":"Intensiv. Care Med."},{"key":"44156_CR24","doi-asserted-by":"publisher","first-page":"e606","DOI":"10.1016\/s1470-2045(14)70344-4","volume":"15","author":"M Ruhnke","year":"2014","unstructured":"Ruhnke, M., Arnold, R. & Gastmeier, P. Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. Lancet Oncol. 15, e606\u2013e619. https:\/\/doi.org\/10.1016\/s1470-2045(14)70344-4 (2014).","journal-title":"Lancet Oncol."},{"key":"44156_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13111918","author":"B Costa","year":"2021","unstructured":"Costa, B., Mart\u00ednez-de-Tejada, G., Gomes, P. A. C., Mc, L. M. & Costa, F. Antimicrobial peptides in the battle against orthopedic implant-related infections: A review. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics13111918 (2021).","journal-title":"Pharmaceutics"},{"key":"44156_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.copbio.2022.102718","volume":"75","author":"CH Chen","year":"2022","unstructured":"Chen, C. H., Bepler, T., Pepper, K., Fu, D. & Lu, T. K. Synthetic molecular evolution of antimicrobial peptides. Curr. Opin. Biotechnol. 75, 102718. https:\/\/doi.org\/10.1016\/j.copbio.2022.102718 (2022).","journal-title":"Curr. Opin. Biotechnol."},{"key":"44156_CR27","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper, J. et al. Highly accurate protein structure prediction with AlphaFold. Nature 596, 583\u2013589. https:\/\/doi.org\/10.1038\/s41586-021-03819-2 (2021).","journal-title":"Nature"},{"key":"44156_CR28","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.tips.2019.04.012","volume":"40","author":"J Koehbach","year":"2019","unstructured":"Koehbach, J. & Craik, D. J. The vast structural diversity of antimicrobial peptides. Trend. Pharmacol. Sci. 40, 517\u2013528. https:\/\/doi.org\/10.1016\/j.tips.2019.04.012 (2019).","journal-title":"Trend. Pharmacol. Sci."},{"key":"44156_CR29","doi-asserted-by":"publisher","first-page":"D288","DOI":"10.1093\/nar\/gkaa991","volume":"49","author":"M Pirtskhalava","year":"2021","unstructured":"Pirtskhalava, M. et al. DBAASP v3: Database of antimicrobial\/cytotoxic activity and structure of peptides as a resource for development of new therapeutics. Nucl. Acid. Res. 49, D288-d297. https:\/\/doi.org\/10.1093\/nar\/gkaa991 (2021).","journal-title":"Nucl. Acid. Res."},{"key":"44156_CR30","doi-asserted-by":"publisher","first-page":"D1087","DOI":"10.1093\/nar\/gkv1278","volume":"44","author":"G Wang","year":"2016","unstructured":"Wang, G., Li, X. & Wang, Z. APD3: The antimicrobial peptide database as a tool for research and education. Nucl. Acid. Res. 44, D1087-1093. https:\/\/doi.org\/10.1093\/nar\/gkv1278 (2016).","journal-title":"Nucl. Acid. Res."},{"key":"44156_CR31","doi-asserted-by":"publisher","first-page":"11692","DOI":"10.1021\/acsnano.3c02365","volume":"17","author":"H Hu","year":"2023","unstructured":"Hu, H. et al. Hybrid biomimetic membrane coated particles-mediated bacterial ferroptosis for acute MRSA pneumonia. ACS Nano 17, 11692\u201311712. https:\/\/doi.org\/10.1021\/acsnano.3c02365 (2023).","journal-title":"ACS Nano"},{"key":"44156_CR32","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2016.00405","volume":"7","author":"A Cruz-Adalia","year":"2016","unstructured":"Cruz-Adalia, A. & Veiga, E. Close encounters of lymphoid cells and bacteria. Front. Immunol. 7, 405. https:\/\/doi.org\/10.3389\/fimmu.2016.00405 (2016).","journal-title":"Front. Immunol."},{"key":"44156_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.chemosphere.2022.137051","volume":"311","author":"Y Fang","year":"2023","unstructured":"Fang, Y. et al. Transcriptomic and metabolomic investigation of molecular inactivation mechanisms in Escherichia coli triggered by graphene quantum dots. Chemosphere 311, 137051. https:\/\/doi.org\/10.1016\/j.chemosphere.2022.137051 (2023).","journal-title":"Chemosphere"},{"key":"44156_CR34","doi-asserted-by":"publisher","DOI":"10.1186\/s40643-021-00472-5","volume":"8","author":"S Lin","year":"2021","unstructured":"Lin, S., Wang, Y., Lu, Q., Zhang, B. & Wu, X. Combined transcriptome and metabolome analyses reveal the potential mechanism for the inhibition of Penicillium digitatum by X33 antimicrobial oligopeptide. Bioresour. Bioprocess. 8, 120. https:\/\/doi.org\/10.1186\/s40643-021-00472-5 (2021).","journal-title":"Bioresour. Bioprocess."},{"key":"44156_CR35","doi-asserted-by":"publisher","first-page":"3337","DOI":"10.1111\/febs.14508","volume":"285","author":"M Camici","year":"2018","unstructured":"Camici, M., Allegrini, S. & Tozzi, M. G. Interplay between adenylate metabolizing enzymes and AMP-activated protein kinase. FEBS J. 285, 3337\u20133352. https:\/\/doi.org\/10.1111\/febs.14508 (2018).","journal-title":"FEBS J."},{"key":"44156_CR36","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1099\/00221287-123-1-27","volume":"123","author":"RK Mehra","year":"1981","unstructured":"Mehra, R. K. & Drabble, W. T. Dual control of the gua operon of Escherichia coli K12 by adenine and guanine nucleotides. Microbiology 123, 27\u201337. https:\/\/doi.org\/10.1099\/00221287-123-1-27 (1981).","journal-title":"Microbiology"},{"key":"44156_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/toxins8030072","author":"C Kong","year":"2016","unstructured":"Kong, C., Neoh, H. M. & Nathan, S. Targeting Staphylococcus aureus toxins: A potential form of anti-virulence therapy. Toxins https:\/\/doi.org\/10.3390\/toxins8030072 (2016).","journal-title":"Toxins"},{"key":"44156_CR38","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/bf00330517","volume":"202","author":"P Recsei","year":"1986","unstructured":"Recsei, P. et al. Regulation of exoprotein gene expression in Staphylococcus aureus by agar. Mol. Gen. Genet. 202, 58\u201361. https:\/\/doi.org\/10.1007\/bf00330517 (1986).","journal-title":"Mol. Gen. Genet."},{"key":"44156_CR39","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1146\/annurev-micro-092611-150039","volume":"66","author":"EJ Capra","year":"2012","unstructured":"Capra, E. J. & Laub, M. T. Evolution of two-component signal transduction systems. Annu. Rev. Microbiol. 66, 325\u2013347. https:\/\/doi.org\/10.1146\/annurev-micro-092611-150039 (2012).","journal-title":"Annu. Rev. Microbiol."},{"key":"44156_CR40","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/22221751.2019.1595984","volume":"8","author":"J Bai","year":"2019","unstructured":"Bai, J. et al. The role of ArlRS in regulating oxacillin susceptibility in methicillin-resistant Staphylococcus aureus indicates it is a potential target for antimicrobial resistance breakers. Emerg. Microbes. Infect. 8, 503\u2013515. https:\/\/doi.org\/10.1080\/22221751.2019.1595984 (2019).","journal-title":"Emerg. Microbes. Infect."},{"key":"44156_CR41","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/21505594.2022.2065961","volume":"13","author":"N Zhao","year":"2022","unstructured":"Zhao, N. et al. Molybdopterin biosynthesis pathway contributes to the regulation of SaeRS two-component system by ClpP in Staphylococcus aureus. Virulence 13, 727\u2013739. https:\/\/doi.org\/10.1080\/21505594.2022.2065961 (2022).","journal-title":"Virulence"},{"key":"44156_CR42","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1098\/rstb.2011.0201","volume":"367","author":"ANJA Lycklama","year":"2012","unstructured":"Lycklama, A. N. J. A. & Driessen, A. J. The bacterial Sec-translocase: Structure and mechanism. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367, 1016\u20131028. https:\/\/doi.org\/10.1098\/rstb.2011.0201 (2012).","journal-title":"Philos. Trans. R. Soc. Lond. B Biol. Sci."},{"key":"44156_CR43","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1038\/nrmicro2874","volume":"10","author":"ME Feltcher","year":"2012","unstructured":"Feltcher, M. E. & Braunstein, M. Emerging themes in SecA2-mediated protein export. Nat. Rev. Microbiol. 10, 779\u2013789. https:\/\/doi.org\/10.1038\/nrmicro2874 (2012).","journal-title":"Nat. Rev. Microbiol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44156-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44156-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:18:33Z","timestamp":1781641113000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-44156-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,17]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["44156"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-44156-6","relation":{"references":[{"id-type":"doi","id":"10.1042\/bsr20182455","asserted-by":"subject"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,17]]},"assertion":[{"value":"10 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the invention patent of the AMP-36 in this article (Patent No.: ZL 2024 1 1479080.3, Status: Granted), the corresponding author Chengyun Zheng is the first inventor and the first author Yanxiao Han is the second inventor. The patent rights belong to the Second Hospital of Shandong University. The patent has not been licensed, and no economic benefits have been obtained by the authors or their institutions from it.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Animal experiments were approved by the Ethics Committee of the Second Hospital of Shandong University with the approval number: No. KYLL-2024SCR001.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"13799"}}